The Endocannabinoid System (ECS) is the second-largest neurotransmitter system in the body. Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands and immune cells. Since its discovery, a huge body of evidence and peer-reviewed research has shown that the ECS is perhaps the most important physiologic system involved in establishing and maintaining human health.
The discovery of the Endocannabinoid System is the single most important medical scientific discovery ever, and will save more lives than the discovery and application of sterile surgical technique.
Clinical therapeutics of botanical medicines and pharmaceutical-derived product development is advancing worldwide. The increase of real-world data for medical conditions such as refractory childhood epilepsy, neurological disorders, oncology, pain and other complex illnesses will continue to shed light on the safety and efficacy of these treatment options.
However, the pace at which laws are changing cannot keep up with the demand for information within medicine’s conventional boundaries.
Collectively, EMHG has been providing medical communications services to health and wellness communities for over 20 years. As leaders in the industry, we feel a tremendous responsibility and urgency to close this educational gap. Our services help educate a growing global community to a broader understanding of how the ECS regulates physiological functions, including:
